We are appointing a new general director ourselves

Biotechnology cosmetics company Ourself announced on Thursday the appointment of James Hartman as CEO.

Hartman has extensive experience in the aesthetics and skin care industry spanning three decades.
Prior to joining Ourself, the director served as Chief Commercial Officer at Alastin Skincare, where under his leadership the company achieved unprecedented growth in the physician-dispensed skin care market, increasing its customer presence 30-fold.

Hartman also held leadership positions at Obagi, Merz Aesthetics and Allergan Aesthetics, and served as president of Hugel Aesthetics, where he oversaw the subsequent approval and commercialization of the company’s neurotoxin throughout the United States. Canada AND Australia.

“The board and I are delighted to welcome you Jim Hartman as the new CEO of Ourself. “His extensive commercial leadership experience and commitment to scientific excellence make Jim the ideal executive to lead us to a leading position in the professional skin care market,” he said Lauren Otsukifounder and president of Ourself.

Hartman’s appointment comes as the Californian cosmetics brand continues to rapidly expand in the medical-professional skin care market.

“I’m excited and honored to build on this Ourselves solid scientific foundation as we expand and drive growth in the market. “Our patented delivery system promises to revolutionize the skin care industry by breaking free from decades of technological limitations,” Hartman said.

“I am excited to work with aesthetic physicians across the country to bring this cutting-edge skin care technology to their practices and patients.”

Founded in 2018, Ourself is a topical skincare brand that uses patented Tiered-Release bubbles to improve volume loss, lines and wrinkles, and uneven skin pigmentation. We developed the first needle-free lip filler ourselves, which is clinically proven to restore volume by local delivery of hyaluronic acid to the lips in two sizes.